These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 21817114

  • 1. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.
    Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
    [Abstract] [Full Text] [Related]

  • 2. Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.
    Oh Y, Swierczewska M, Kim TH, Lim SM, Eom HN, Park JH, Na DH, Kim K, Lee KC, Pomper MG, Lee S.
    J Control Release; 2015 Dec 28; 220(Pt B):671-81. PubMed ID: 26381901
    [Abstract] [Full Text] [Related]

  • 3. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors.
    Kim B, Seo JH, Lee KY, Park B.
    Int J Oncol; 2020 Mar 28; 56(3):821-834. PubMed ID: 32124960
    [Abstract] [Full Text] [Related]

  • 4. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
    Guo X, Meng Y, Sheng X, Guan Y, Zhang F, Han Z, Kang Y, Tai G, Zhou Y, Cheng H.
    Anticancer Drugs; 2017 Jan 28; 28(1):66-74. PubMed ID: 27603596
    [Abstract] [Full Text] [Related]

  • 5. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
    Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB.
    J Biol Chem; 2010 Nov 12; 285(46):35418-27. PubMed ID: 20837473
    [Abstract] [Full Text] [Related]

  • 6. Shogaol overcomes TRAIL resistance in colon cancer cells via inhibiting of survivin.
    Hwang JS, Lee HC, Oh SC, Lee DH, Kwon KH.
    Tumour Biol; 2015 Nov 12; 36(11):8819-29. PubMed ID: 26063410
    [Abstract] [Full Text] [Related]

  • 7. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB.
    Du J, Wang Y, Chen D, Ji G, Ma Q, Liao S, Zheng Y, Zhang J, Hou Y.
    Cancer Lett; 2016 Dec 28; 383(2):145-153. PubMed ID: 27721019
    [Abstract] [Full Text] [Related]

  • 8. Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.
    Gupta SC, Reuter S, Phromnoi K, Park B, Hema PS, Nair M, Aggarwal BB.
    J Biol Chem; 2011 Jan 14; 286(2):1134-46. PubMed ID: 21078664
    [Abstract] [Full Text] [Related]

  • 9. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo.
    Qiao X, Wang X, Shang Y, Li Y, Chen SZ.
    Cancer Commun (Lond); 2018 Jul 03; 38(1):43. PubMed ID: 29970185
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
    Woo JK, Kang JH, Jang YS, Ro S, Cho JM, Kim HM, Lee SJ, Oh SH.
    Oncol Rep; 2015 Apr 03; 33(4):1947-55. PubMed ID: 25672292
    [Abstract] [Full Text] [Related]

  • 11. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
    Chen L, Meng Y, Sun Q, Zhang Z, Guo X, Sheng X, Tai G, Cheng H, Zhou Y.
    Cell Death Dis; 2016 Aug 11; 7(8):e2334. PubMed ID: 27512955
    [Abstract] [Full Text] [Related]

  • 12. Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation.
    Na YJ, Lee DH, Kim JL, Kim BR, Park SH, Jo MJ, Jeong S, Kim HJ, Lee SY, Jeong YA, Oh SC.
    Int J Biochem Cell Biol; 2017 Aug 11; 89():147-156. PubMed ID: 28624529
    [Abstract] [Full Text] [Related]

  • 13. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY.
    Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429
    [Abstract] [Full Text] [Related]

  • 14. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
    Kim JY, Kim EH, Kim SU, Kwon TK, Choi KS.
    Carcinogenesis; 2010 Mar 15; 31(3):367-75. PubMed ID: 19939880
    [Abstract] [Full Text] [Related]

  • 15. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 16. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
    Lee YS, Lee DH, Jeong SY, Park SH, Oh SC, Park YS, Yu J, Choudry HA, Bartlett DL, Lee YJ.
    J Cell Biochem; 2019 Jan 15; 120(1):928-939. PubMed ID: 30160785
    [Abstract] [Full Text] [Related]

  • 17. The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in vivo.
    Zhu H, Zhao F, Yu S, He J, Deng L, Yi C, Huang Y.
    Int J Mol Med; 2012 Nov 15; 30(5):1087-94. PubMed ID: 22922573
    [Abstract] [Full Text] [Related]

  • 18. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L, Wang Y, Zheng H, Zhang D, Wu X, Sun G, Yang T.
    J Chemother; 2017 Jun 15; 29(3):179-188. PubMed ID: 28067150
    [Abstract] [Full Text] [Related]

  • 19. Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.
    Raviv Z, Zilberberg A, Cohen S, Reischer-Pelech D, Horrix C, Berger MR, Rosin-Arbesfeld R, Flescher E.
    Br J Pharmacol; 2011 Nov 15; 164(5):1433-44. PubMed ID: 21486277
    [Abstract] [Full Text] [Related]

  • 20. Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells.
    Tang SY, Zhong MZ, Yuan GJ, Hou SP, Yin LL, Jiang H, Yu ZΥ.
    Oncol Rep; 2013 Feb 15; 29(2):474-80. PubMed ID: 23135489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.